🔗 Share this article

Treasury head Rachel Reeves has stated she is planning "targeted steps to deal with cost of living issues" in the upcoming financial statement.

During an interview with media outlets, she noted that reducing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 advanced economies this year and the following year.

Possible Utility Cost Interventions

Reports indicate the government could intervene to bring down energy bills, such as by slashing the present 5% rate of VAT applied on energy supplies.

Another possibility is to cut some of the policy costs presently included in bills.

Budgetary Constraints and Expert Predictions

The government will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such measures.

The consensus from most analysts is that the Chancellor will have to announce tax rises or budget cuts in order to adhere to her declared fiscal targets.

Previously on Thursday, calculations suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of projections.

"There's a collective job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor informed reporters in Washington, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Issues

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent information from the fiscal watchdog had not changed her pledge to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with growing geopolitical and commercial tensions for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."

International Trade Tensions

Addressing worries about the UK's commercial links with the Asian nation she said: "Our security interests always come first."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to threaten an extra 100% import tax on goods from China, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese move "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the US offer to join its conflict with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the action was "damaging for the global economy and generates further challenges."

"In my view there are areas where we must confront China, but there are also significant prospects to export to Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was cooperating with international partners "on our own essential resources approach, so that we are less reliant."

Health Service Drug Costs and Investment

Reeves also recognized that the price the NHS spends on drugs could rise as a consequence of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and capital.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning investments in the UK, with several attributing the low prices they are receiving.

Last month, the government science advisor said the price the health service spends on medicines would have to increase to halt companies and pharmaceutical investment leaving the UK.

Reeves informed the BBC: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other EU nations."

"The objective is to guarantee that people getting care from the National Health Service are can receive the top life-saving medicines in the globe. And so we are examining all of that, and... aiming to attract additional investment into Britain."